| Stage | MDLZ | % of rev | SMPL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $10.0B | 100.00% | $333M | 100.00% | MDLZ ×29.90 |
| Gross profit | $3.9B | 39.37% | $113M | 34.00% | MDLZ +5.4pp |
| Operating income | $1.8B | 17.64% | $46M | 13.77% | MDLZ +3.9pp |
| Pre-tax income | $1.7B | 17.27% | $41M | 12.31% | MDLZ +5.0pp |
| Net income | $1.3B | 13.12% | $30M | 9.15% | MDLZ +4.0pp |
| Stage | MDLZ | SMPL | Gap · A − B |
|---|---|---|---|
| Revenue | $10.0B100.00% | $333M100.00% | MDLZ ×29.90 |
| Gross profit | 39.37%$3.9B | 34.00%$113M | MDLZ +5.4pp |
| Operating income | 17.64%$1.8B | 13.77%$46M | MDLZ +3.9pp |
| Pre-tax income | 17.27%$1.7B | 12.31%$41M | MDLZ +5.0pp |
| Net income |
| 13.12%$1.3B |
| 9.15%$30M |
| MDLZ +4.0pp |